183 related articles for article (PubMed ID: 23625626)
1. Survival of pediatric patients after relapsed osteosarcoma: the St. Jude Children's Research Hospital experience.
Leary SE; Wozniak AW; Billups CA; Wu J; McPherson V; Neel MD; Rao BN; Daw NC
Cancer; 2013 Jul; 119(14):2645-53. PubMed ID: 23625626
[TBL] [Abstract][Full Text] [Related]
2. Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution Experience.
Berlanga P; Cañete A; Salom M; Montalar J; Guasp M; Marco A; Castel V
J Pediatr Hematol Oncol; 2016 Apr; 38(3):176-81. PubMed ID: 26925713
[TBL] [Abstract][Full Text] [Related]
3. Postrelapse survival in osteosarcoma of the extremities: prognostic factors for long-term survival.
Ferrari S; Briccoli A; Mercuri M; Bertoni F; Picci P; Tienghi A; Del Prever AB; Fagioli F; Comandone A; Bacci G
J Clin Oncol; 2003 Feb; 21(4):710-5. PubMed ID: 12586810
[TBL] [Abstract][Full Text] [Related]
4. Outcome after local recurrence of osteosarcoma: the St. Jude Children's Research Hospital experience (1970-2000).
Rodriguez-Galindo C; Shah N; McCarville MB; Billups CA; Neel MN; Rao BN; Daw NC
Cancer; 2004 May; 100(9):1928-35. PubMed ID: 15112274
[TBL] [Abstract][Full Text] [Related]
5. Surgical resection of relapse may improve postrelapse survival of patients with localized osteosarcoma.
Wong KC; Lee V; Shing MM; Kumta S
Clin Orthop Relat Res; 2013 Mar; 471(3):814-9. PubMed ID: 22972657
[TBL] [Abstract][Full Text] [Related]
6. Recurrent osteosarcoma with a single pulmonary metastasis: a multi-institutional review.
Daw NC; Chou AJ; Jaffe N; Rao BN; Billups CA; Rodriguez-Galindo C; Meyers PA; Huh WW
Br J Cancer; 2015 Jan; 112(2):278-82. PubMed ID: 25422914
[TBL] [Abstract][Full Text] [Related]
7. Is there a role for chemotherapy after local relapse in high-grade osteosarcoma?
Palmerini E; Torricelli E; Cascinu S; Pierini M; De Paolis M; Donati D; Cesari M; Longhi A; Abate M; Paioli A; Setola E; Ferrari S
Pediatr Blood Cancer; 2019 Aug; 66(8):e27792. PubMed ID: 31058424
[TBL] [Abstract][Full Text] [Related]
8. Survival after recurrent osteosarcoma: data from 3 European Osteosarcoma Intergroup (EOI) randomized controlled trials.
Gelderblom H; Jinks RC; Sydes M; Bramwell VH; van Glabbeke M; Grimer RJ; Hogendoorn PC; McTiernan A; Lewis IJ; Nooij MA; Taminiau AH; Whelan J;
Eur J Cancer; 2011 Apr; 47(6):895-902. PubMed ID: 21216138
[TBL] [Abstract][Full Text] [Related]
9. Survival after second and subsequent recurrences in osteosarcoma: a retrospective multicenter analysis.
Tirtei E; Asaftei SD; Manicone R; Cesari M; Paioli A; Rocca M; Ferrari S; Fagioli F
Tumori; 2018 Jun; 104(3):202-206. PubMed ID: 30086698
[TBL] [Abstract][Full Text] [Related]
10. Should High-grade Extraosseous Osteosarcoma Be Treated With Multimodality Therapy Like Other Soft Tissue Sarcomas?
Fan Z; Patel S; Lewis VO; Guadagnolo BA; Lin PP
Clin Orthop Relat Res; 2015 Nov; 473(11):3604-11. PubMed ID: 26197952
[TBL] [Abstract][Full Text] [Related]
11. Pirarubicin versus doxorubicin in neoadjuvant/adjuvant chemotherapy for stage IIB limb high-grade osteosarcoma: does the analog matter?
Yu W; Tang L; Lin F; Yao Y; Shen Z
Med Oncol; 2015 Jan; 32(1):307. PubMed ID: 25432694
[TBL] [Abstract][Full Text] [Related]
12. Should contralateral exploratory thoracotomy be advocated for children with osteosarcoma and early unilateral pulmonary metastases?
Karplus G; McCarville MB; Smeltzer MP; Spyridis G; Rao BN; Davidoff A; Li CS; Shochat S
J Pediatr Surg; 2009 Apr; 44(4):665-71. PubMed ID: 19361624
[TBL] [Abstract][Full Text] [Related]
13. Experience of pediatric osteosarcoma of the extremity at a single institution in Taiwan: prognostic factors and impact on survival.
Hung GY; Yen HJ; Yen CC; Chen WM; Chen PC; Wu HT; Chiou HJ; Chang WH; Hsu HE
Ann Surg Oncol; 2015 Apr; 22(4):1080-7. PubMed ID: 25323470
[TBL] [Abstract][Full Text] [Related]
14. Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.
Hawkins DS; Arndt CA
Cancer; 2003 Dec; 98(11):2447-56. PubMed ID: 14635080
[TBL] [Abstract][Full Text] [Related]
15. Carboplatin/ifosfamide window therapy for osteosarcoma: results of the St Jude Children's Research Hospital OS-91 trial.
Meyer WH; Pratt CB; Poquette CA; Rao BN; Parham DM; Marina NM; Pappo AS; Mahmoud HH; Jenkins JJ; Harper J; Neel M; Fletcher BD
J Clin Oncol; 2001 Jan; 19(1):171-82. PubMed ID: 11134210
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing survival after recurrence in osteosarcoma: A report from the Children's Oncology Group.
Spraker-Perlman HL; Barkauskas DA; Krailo MD; Meyers PA; Schwartz CL; Doski J; Gorlick R; Janeway KA; Isakoff MS
Pediatr Blood Cancer; 2019 Jan; 66(1):e27444. PubMed ID: 30255612
[TBL] [Abstract][Full Text] [Related]
17. Frontline treatment of localized osteosarcoma without methotrexate: results of the St. Jude Children's Research Hospital OS99 trial.
Daw NC; Neel MD; Rao BN; Billups CA; Wu J; Jenkins JJ; Quintana J; Luchtman-Jones L; Villarroel M; Santana VM
Cancer; 2011 Jun; 117(12):2770-8. PubMed ID: 21656756
[TBL] [Abstract][Full Text] [Related]
18. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
Meyers PA; Schwartz CL; Krailo MD; Healey JH; Bernstein ML; Betcher D; Ferguson WS; Gebhardt MC; Goorin AM; Harris M; Kleinerman E; Link MP; Nadel H; Nieder M; Siegal GP; Weiner MA; Wells RJ; Womer RB; Grier HE;
J Clin Oncol; 2008 Feb; 26(4):633-8. PubMed ID: 18235123
[TBL] [Abstract][Full Text] [Related]
19. Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
Bielack SS; Smeland S; Whelan JS; Marina N; Jovic G; Hook JM; Krailo MD; Gebhardt M; Pápai Z; Meyer J; Nadel H; Randall RL; Deffenbaugh C; Nagarajan R; Brennan B; Letson GD; Teot LA; Goorin A; Baumhoer D; Kager L; Werner M; Lau CC; Sundby Hall K; Gelderblom H; Meyers P; Gorlick R; Windhager R; Helmke K; Eriksson M; Hoogerbrugge PM; Schomberg P; Tunn PU; Kühne T; Jürgens H; van den Berg H; Böhling T; Picton S; Renard M; Reichardt P; Gerss J; Butterfass-Bahloul T; Morris C; Hogendoorn PC; Seddon B; Calaminus G; Michelagnoli M; Dhooge C; Sydes MR; Bernstein M;
J Clin Oncol; 2015 Jul; 33(20):2279-87. PubMed ID: 26033801
[TBL] [Abstract][Full Text] [Related]
20. Carboplatin and doxorubicin in treatment of pediatric osteosarcoma: a 9-year single institute experience in the Northern Region of Thailand.
Choeyprasert W; Natesirinilkul R; Charoenkwan P; Sittipreechacharn S
Asian Pac J Cancer Prev; 2013; 14(2):1101-6. PubMed ID: 23621194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
